| American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis BH Hahn, MA Mcmahon, A Wilkinson, WD Wallace, DI Daikh, ... Arthritis care & research 64 (6), 797-808, 2012 | 1740 | 2012 |
| Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis CS Crowson, S Rollefstad, E Ikdahl, GD Kitas, PLCM Van Riel, SE Gabriel, ... Annals of the rheumatic diseases 77 (1), 48-54, 2018 | 269 | 2018 |
| Dysfunctional proinflammatory high‐density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus M McMahon, J Grossman, B Skaggs, J FitzGerald, L Sahakian, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 243 | 2009 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 228 | 2017 |
| Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease GA Karpouzas, J Malpeso, TY Choi, D Li, S Munoz, MJ Budoff Annals of the Rheumatic Diseases 73 (10), 1797-1804, 2014 | 208 | 2014 |
| A panel of biomarkers is associated with increased risk of the presence and progression of atherosclerosis in women with systemic lupus erythematosus M McMahon, BJ Skaggs, JM Grossman, L Sahakian, J FitzGerald, ... Arthritis & Rheumatology 66 (1), 130-139, 2014 | 144 | 2014 |
| Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use SI Mavrogeni, GD Kitas, T Dimitroulas, PP Sfikakis, P Seo, S Gabriel, ... International journal of cardiology 217, 135-148, 2016 | 139 | 2016 |
| Dubois' lupus erythematosus and related syndromes e-book: expert consult-online D Wallace, BH Hahn Elsevier Health Sciences, 2012 | 133 | 2012 |
| Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries CS Crowson, SE Gabriel, AG Semb, PLCM van Riel, G Karpouzas, ... Rheumatology 56 (7), 1102-1110, 2017 | 128 | 2017 |
| Prevention of cardiovascular disease in rheumatoid arthritis I Hollan, PH Dessein, N Ronda, MC Wasko, E Svenungsson, S Agewall, ... Autoimmunity reviews 14 (10), 952-969, 2015 | 103 | 2015 |
| Low physical activity is associated with proinflammatory high‐density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus ER Volkmann, JM Grossman, LJ Sahakian, BJ Skaggs, J FitzGerald, ... Arthritis Care & Research: Official Journal of the American College of …, 2010 | 87 | 2010 |
| Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing D Dumitrescu, RJ Oudiz, G Karpouzas, A Hovanesyan, A Jayasinghe, ... PloS one 5 (12), e14293, 2010 | 83 | 2010 |
| Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D study T Takeuchi, C Thorne, G Karpouzas, S Sheng, W Xu, R Rao, K Fei, B Hsu, ... Annals of the rheumatic diseases 76 (12), 2001-2008, 2017 | 76 | 2017 |
| Cellular and molecular mechanisms of regulation of autoantibody production in lupus BH Hahn, F Ebling, RR Singh, RP Singh, G Karpouzas, A La Cava Annals of the New York Academy of Sciences 1051 (1), 433-441, 2005 | 75 | 2005 |
| Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high‐risk lesions GA Karpouzas, SR Ormseth, E Hernandez, MJ Budoff Arthritis & rheumatology 72 (9), 1467-1475, 2020 | 67 | 2020 |
| Impact of cumulative inflammation, cardiac risk factors and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis. GA Karpouzas, SR Ormseth, E Hernandez, M Budoff Arthritis Rheumatol. 2019 Sep 18. doi: 10.1002/art.41122. [Epub ahead of print], 2019 | 62 | 2019 |
| Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients. KA Boki, U Dafni, GA Karpouzas, C Papasteriades, AA Drosos, ... British journal of rheumatology 36 (10), 1059-1066, 1997 | 61 | 1997 |
| Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis CS Crowson, S Rollefstad, GD Kitas, PLCM Van Riel, SE Gabriel, ... PLoS One 12 (3), e0174656, 2017 | 58 | 2017 |
| New developments in the pathogenesis of articular cartilage calcification GA Karpouzas, RA Terkeltaub Current rheumatology reports 1 (2), 121-127, 1999 | 51 | 1999 |
| Correlates and predictors of disability in vulnerable US Hispanics with rheumatoid arthritis GA Karpouzas, S Dolatabadi, R Moran, N Li, PM Nicassio, MH Weisman Arthritis care & research 64 (9), 1274-1281, 2012 | 49 | 2012 |
Matthew J. Budoff MDDavid Geffen School of Medicine at UCLA在 ucla.edu 的电子邮件经过验证
